2018 Antithrombin III Testing Market: USA, Europe, Japan--Country Forecasts, Innovative Technologies, Competitive Strategies

The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next five years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and AT III testing specifically, will become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the AT III testing closer to the patient, creating additional opportunities and challenges for suppliers.

This report presents a detailed analysis of the AT III testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5-year test volume forecasts by country and market segment.

The report examines market applications of chromogenic substrates, monoclonal antibodies, immunoassays, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

Contains 197 pages and 8 tables

I. Introduction
II. Worldwide Market and Technology Overview
A. Introduction
B. Antithrombin III: Clinical Significance: Clinical Significance
and Current Laboratory Procedures
C. Instrumentation Review
- Introduction
- Benk Hemolab
- Benk TRT Thrombotimer
- Bio/Data MCA 310
- Bio/Data MCA 210
- Bio/Data PAP-4C D/4D/4C
- Cardiovascular Diagnostics COAG
- Diagnostica Stago STA Compact
- Diagnostica Stago STA-R
- Diagnostica Stago Star 4/8
- Helena Laboratories Cascade 480
- Helena Laboratories Cascade M
- Helena Laboratories PACKS-4
- Helena THOR
- Instrumentation Laboratory ACL 100 and 1000 series
- Instrumentation Laboratory ACL6000
- Instrumentation Laboratory ACL7000
- Instrumentation Laboratory ACL9000
- Instrumentation Laboratory Electra 1000C
- Instrumentation Laboratory Electra 1400C
- Instrumentation Laboratory Electra 1600/C
- Instrumentation Laboratory Electra 1800C
- Instrumentation Laboratory Futura
- ITC Hemochron 8000
- Roche Diagnostics CoaguChek
- Siemens BCS
- Siemens BCT
- Siemens BF II/Fibrintimer Series

- Sysmex CA-50
- Sysmex CA-500
- Sysmex CA-1500
- Sysmex CA-5000/CA-1000
- Sysmex CA-6000
- Sysmex CA-7000
- Teco Coatron II/Jr./AccuStasis 5000
- Trinity Biotech Amax CS190
- Trinity Biotech Amax CS400
- Trinity Biotech Coag-A-Mate Max
- Trinity Biotech KC 40, 4A, 1A Series
- Trinity Biotech MDA 180
- Trinity Biotech Coag-A-Mate MTX
- Trinity Biotech Coag-A-Mate RA4
- Trinity Biotech Coag-A-Mate XC/Plus
- Trinity Biotech Coag-A-Mate XM
D. Major in Vitro Diagnostic Technologies and Their
Potential Applications
1. Chromogenic Substrates
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
a. Applications
b. Technological Principle
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- EMIT
- Dot Immunobinding Assays
- Capillary Immunoassays
- Enzyme Amplification
- Electrochemical Immunoassay
d. Fluorescent Immunoassays
- Fluorescence Polarization
- Time-Resolved Pulse Fluorescence
- Fluorescence Lifetime
e. Latex Agglutination
f. Immunoprecipitation
4. Microcomputers


5. Automation
6. Robotics
7. DNA Probes
a. Overview
b. Amplification Methods
- PCR
- Ligase Chain Reaction
- Branched DNA
- Q-Beta Replicase
- NASBA
- SDA
- 3 SR
- HPA
- Two-Tiered System
- LAT
8. Artificial Intelligence
9. Dry Chemistry
10. Biosensors
III. France: Test Volume Forecasts by Market Segment
IV. Germany: Test Volume Forecasts by Market Segment
V. Italy: Test Volume Forecasts by Market Segment
VI. Japan: Test Volume Forecasts by Market Segment
VII. Spain: Test Volume Forecasts by Market Segment
VIII. UK: Test Volume Forecasts by Market Segment
IX. USA: Test Volume Forecasts by Market Segment
X. Design Criteria For Decentralized Testing Products
XI. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts

D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types Of Distributors
7. Market Segmentation
XII. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XIII. Competitive Assessments
- Abbott
- ADI/American Diagnostica
- Alere/Biosite/Inverness
- Axis-Shield
- Beckman Coulter
- Becton Dickinson
- Bio/Data Corporation
- Chrono-Log
- Corgenix Medical
- Diagnostica Stago/Trinity Biotech
- Grifols
- Helena Laboratories
- HYPEN BioMed
- Instrumentation Laboratory
- ITC
- Roche
- Siemens
- Sienco
- Sysmex
- Thermo Fischer
- ZyCare/Alere

List Of Tables

List of Tables
Major Companies Developing or Marketing Antithrombin III Tests
France
Antithrombin III Test Volume Forecasts by Market Segment
Germany
Antithrombin III Test Volume Forecasts by Market Segment
Italy
Antithrombin III Test Volume Forecasts by Market Segment
Japan
Antithrombin III Test Volume Forecasts by Market Segment
Spain
Antithrombin III Test Volume Forecasts by Market Segment
U.K.
Antithrombin III Test Volume Forecasts by Market Segment
U.S.A.
Antithrombin III Test Volume Forecasts by Market Segment

Rett Syndrome - Pipeline Review, H2 2018

Rett Syndrome - Pipeline Review, H2 2018The latest Pharmaceutical and Healthcare disease pipeline guide Rett Syndrome - Pipeline Review, H2 2018, provides an overview of the Rett Syndrome (Central Nervous

USD 2000 View Report

Binge Eating Disorder - Pipeline Review, H2 2018

Binge Eating Disorder - Pipeline Review, H2 2018The latest Pharmaceutical and Healthcare disease pipeline guide Binge Eating Disorder - Pipeline Review, H2 2018, provides an overview of the Binge Eating

USD 2000 View Report

2018-2022 Antithrombin III: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next five years. New specific and sensitive markers of

USD 4350 View Report

Antithrombin III Testing Market 2021: Country Forecasts, Innovative Technologies, Competitive Strategies--USA, EU5, Japan

The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis

USD 4350 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available